KalVista Pharmaceuticals (KALV)
(Delayed Data from NSDQ)
$10.49 USD
-0.51 (-4.64%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $10.52 +0.03 (0.29%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
12/05/2024
Time: -- |
10/2024 | $-0.95 | 2.11% |
Earnings Summary
For their last quarter, KalVista Pharmaceuticals (KALV) reported earnings of -$0.87 per share, beating the Zacks Consensus Estimate of $-0.95 per share. This reflects a positive earnings surprise of 8.42%. Look out for KALV's next earnings release expected on December 05, 2024. For the next earning release, we expect the company to report earnings of -$0.95 per share, reflecting a year-over-year decrease of 18.75%.
Earnings History
Price & Consensus
Zacks News for KALV
Are Medical Stocks Lagging Cabaletta Bio (CABA) This Year?
KALV: What are Zacks experts saying now?
Zacks Private Portfolio Services